Loading company
Anixa Biosciences Inc
ANIX · Nasdaq · ·
$2.84+1.4%Sep 29 close
- 1M
- -18.4%
- 6M
- +13.6%
- 1Y
- -13.9%
- 5Y
- -40.8%
ANIX · Nasdaq · ·
$2.84+1.4%Sep 29 close
The quarter ending October 31, 2023, against the same quarter a year earlier.
| Measure | 3 months toOct 31, 2023 | 3 months toJan 31, 2022 | Change |
|---|---|---|---|
| Total Revenue | $0.00 | $513K | -100.00% |
| Profit | -$2.6M | -$2.3M | -15.41% |
| Profit per share | -$0.08 | -$0.07 | -14.29% |
| Free Cash Flow | -$1.4M | -$1.3M | -5.76% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Anixa Biosciences Inc has no earnings call transcript available.